de Commonwealth Equity Services Bio-Techne TECH Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 684 k | Vender |
9,682
-1,301
| -12% | -USD 70.3 k | ﹤0.01% | 3036 |
|
|
2026
Q1 | USD 574 k | Vender |
10,983
-2,917
| -21% | -USD 175 k | ﹤0.01% | 3095 |
|
|
2025
Q4 | USD 817 k | Comprar |
13,900
+274
| +2% | +USD 16.6 k | ﹤0.01% | 2754 |
|
|
2025
Q3 | USD 758 k | Vender |
13,626
-897
| -6% | -USD 48 k | ﹤0.01% | 2814 |
|
|
2025
Q2 | USD 747 k | Comprar |
14,523
+49
| +0.3% | +USD 2.46 k | ﹤0.01% | 2810 |
|
|
2025
Q1 | USD 849 k | Vender |
14,474
-1,823
| -11% | -USD 124 k | ﹤0.01% | 2593 |
|
|
2024
Q4 | USD 1.17 M | Vender |
16,297
-11
| -0.1% | -USD 808 | ﹤0.01% | 2272 |
|
|
2024
Q3 | USD 1.3 M | Vender |
16,308
-1,198
| -7% | -USD 90 k | ﹤0.01% | 2134 |
|
|
2024
Q2 | USD 1.25 M | Vender |
17,506
-934
| -5% | -USD 68.7 k | ﹤0.01% | 2115 |
|
|
2024
Q1 | USD 1.3 M | Comprar |
18,440
+3,775
| +26% | +USD 270 k | ﹤0.01% | 2072 |
|
|
2023
Q4 | USD 1.13 M | Vender |
14,665
-1,051
| -7% | -USD 69.2 k | ﹤0.01% | 2094 |
|
|
2023
Q3 | USD 1.07 M | Comprar |
15,716
+298
| +2% | +USD 23.5 k | ﹤0.01% | 2028 |
|
|
2023
Q2 | USD 1.26 M | Vender |
15,418
-810
| -5% | -USD 65.1 k | ﹤0.01% | 1935 |
|
|
2023
Q1 | USD 1.2 M | Vender |
16,228
-7,946
| -33% | -USD 612 k | ﹤0.01% | 1910 |
|
|
2022
Q4 | USD 2 M | Vender |
24,174
-650
| -3% | -USD 51.6 k | ﹤0.01% | 1499 |
|
|
2022
Q3 | USD 1.76 M | Comprar |
24,824
+1,076
| +5% | +USD 93 k | ﹤0.01% | 1504 |
|
|
2022
Q2 | USD 2.06 M | Comprar |
23,748
+2,076
| +10% | +USD 195 k | 0.01% | 1414 |
|
|
2022
Q1 | USD 2.35 M | Vender |
21,672
-160
| -0.7% | -USD 16.5 k | 0.01% | 1408 |
|
|
2021
Q4 | USD 2.82 M | Vender |
21,832
-13,632
| -38% | -USD 1.67 M | 0.01% | 1263 |
|
|
2021
Q3 | USD 4.3 M | Comprar |
35,464
+13,832
| +64% | +USD 1.68 M | 0.01% | 953 |
|
|
2021
Q2 | USD 2.44 M | Vender |
21,632
-1,840
| -8% | -USD 194 k | 0.01% | 1298 |
|
|
2021
Q1 | USD 2.24 M | Comprar |
23,472
+1,420
| +6% | +USD 130 k | 0.01% | 1245 |
|
|
2020
Q4 | USD 1.75 M | Vender |
22,052
-5,348
| -20% | -USD 387 k | 0.01% | 1299 |
|
|
2020
Q3 | USD 1.7 M | Comprar |
27,400
+10,152
| +59% | +USD 660 k | 0.01% | 1185 |
|
|
2020
Q2 | USD 1.14 M | Vender |
17,248
-860
| -5% | -USD 51.5 k | ﹤0.01% | 1348 |
|
|
2020
Q1 | USD 858 k | Vender |
18,108
-116
| -0.6% | -USD 5.8 k | ﹤0.01% | 1343 |
|
|
2019
Q4 | USD 1 M | Vender |
18,224
-176
| -1% | -USD 9.23 k | ﹤0.01% | 1423 |
|
|
2019
Q3 | USD 900 k | Comprar |
18,400
+984
| +6% | +USD 49.3 k | ﹤0.01% | 1424 |
|
|
2019
Q2 | USD 907 k | Comprar |
17,416
+2,052
| +13% | +USD 103 k | ﹤0.01% | 1402 |
|
|
2019
Q1 | USD 762 k | Comprar |
15,364
+604
| +4% | +USD 27.2 k | ﹤0.01% | 1480 |
|
|
2018
Q4 | USD 534 k | Comprar |
14,760
+232
| +2% | +USD 9.7 k | ﹤0.01% | 1594 |
|
|
2018
Q3 | USD 741 k | Vender |
14,528
-27,296
| -65% | -USD 1.21 M | ﹤0.01% | 1511 |
|
|
2018
Q2 | USD 1.55 M | Comprar |
41,824
+25,824
| +161% | +USD 986 k | 0.01% | 1043 |
|
|
2018
Q1 | USD 604 k | Comprar |
16,000
+28
| +0.2% | +USD 989 | ﹤0.01% | 1587 |
|
|
2017
Q4 | USD 517 k | Comprar |
15,972
+48
| +0.3% | +USD 1.52 k | ﹤0.01% | 1670 |
|
|
2017
Q3 | USD 481 k | Vender |
15,924
-28
| -0.2% | -USD 831 | ﹤0.01% | 1639 |
|
|
2017
Q2 | USD 469 k | Comprar |
15,952
+200
| +1% | +USD 5.47 k | ﹤0.01% | 1612 |
|
|
2017
Q1 | USD 400 k | Vender |
15,752
-56
| -0.4% | -USD 1.45 k | ﹤0.01% | 1659 |
|
|
2016
Q4 | USD 406 k | Comprar |
15,808
+280
| +2% | +USD 7.36 k | ﹤0.01% | 1535 |
|
|
2016
Q3 | USD 425 k | Mantener |
15,528
| – | – | ﹤0.01% | 1470 |
|
|
2016
Q2 | USD 438 k | Mantener |
15,528
| – | – | ﹤0.01% | 1441 |
|
|
2016
Q1 | USD 367 k | Comprar |
15,528
+4
| +0% | +USD 88 | ﹤0.01% | 1501 |
|
|
2015
Q4 | USD 349 k | Comprar |
15,524
+3,400
| +28% | +USD 77.5 k | ﹤0.01% | 1500 |
|
|
2015
Q3 | USD 280 k | Mantener |
12,124
| – | – | ﹤0.01% | 1595 |
|
|
2015
Q2 | USD 298 k | Comprar |
12,124
+4
| +0% | +USD 100 | ﹤0.01% | 1646 |
|
|
2015
Q1 | USD 304 k | Vender |
12,120
-360
| -3% | -USD 8.56 k | ﹤0.01% | 1628 |
|
|
2014
Q4 | USD 288 k | Mantener |
12,480
| – | – | ﹤0.01% | 1586 |
|
|
2014
Q3 | USD 292 k | Vender |
12,480
-1,200
| -9% | -USD 28.1 k | ﹤0.01% | 1568 |
|
|
2014
Q2 | USD 317 k | Comprar |
13,680
+48
| +0.4% | +USD 1.06 k | ﹤0.01% | 1507 |
|
|
2014
Q1 | USD 291 k | Comprar |
13,632
+364
| +3% | +USD 8.19 k | ﹤0.01% | 1501 |
|
|
2013
Q4 | USD 314 k | Mantener |
13,268
| – | – | ﹤0.01% | 1413 |
|
|
2013
Q3 | USD 266 k | Vender |
13,268
-188
| -1% | -USD 3.57 k | ﹤0.01% | 1444 |
|
|
2013
Q2 | USD 232 k | Comprar |
+13,456
| Nuevas | +USD 223 k | ﹤0.01% | 1481 |
|
Otros fondos que tienen TECH en su cartera
Posición de Commonwealth Equity Services en TECH: resumen de T2 2026
Commonwealth Equity Services redujo su participación en Bio-Techne (TECH) en 12% durante T2 2026, al vender acciones por un valor estimado de USD 70.3 k, y conservó 9,682 acciones valuadas en USD 684 k. La posición representa ﹤0.01% de la cartera y ocupa el puesto #3036.
Commonwealth Equity Services reportó por primera vez una posición en TECH en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 4.3 M en T3 2021. Al cierre de T2 2026, 598 fondos que sigue Wall St. Rank mantienen una posición en TECH.
- Al cierre de T2 2026, Commonwealth Equity Services tenía 9,682 acciones de Bio-Techne con un valor de USD 684 k.
- Commonwealth Equity Services vendió 1,301 acciones de Bio-Techne en T2 2026, por un valor estimado de USD 70.3 k.
- Bio-Techne representó ﹤0.01% de la cartera de Commonwealth Equity Services en T2 2026 y fue su posición número 3036.
- Commonwealth Equity Services reportó por primera vez una posición en Bio-Techne en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Commonwealth Equity Services en Bio-Techne alcanzó su máximo de USD 4.3 M en T3 2021.
- Al cierre de T2 2026, 598 fondos que sigue Wall St. Rank tenían Bio-Techne en cartera.
Según el Informe 13F de Commonwealth Equity Services correspondiente a T2 2026, presentado el 29 jul 2026.